A clinical trial to study the effect of mifepristone to hasten the process of labour
- Conditions
- Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2021/03/032211
- Lead Sponsor
- SHAILY TYAGI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients giving consent for study
Singleton pregnancy
Gestational age >= 40 completed weeks (Gestation age confirmed by earliest ultrasound and reliable date of last menstrual period) with cephalic presentation
Adequate pelvis
Bishop score <6
Reactive NST
Age >18 â?? 35 year.
Patients not giving consent for the study
Multiple pregnancy
Any obstetrics contraindication for induction of labour (previous scar on uterus, any coagulation failure, placenta previa)
Patients with any other associated medical condition like gestational diabetes mellitus, hypertension, sepsis, pyrexia, disease which contraindicates the use of mifepristone like adrenal insufficiency
Estimated fetal weight >= 4kg
Parity >4
Oligohydromnios
Fetal growth restriction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Improvement in bishopâ??s score <br/ ><br>2.Duration of induction to active phase of labour <br/ ><br>3.Requirement of dinoprostone gel and its mean dose <br/ ><br>4.Requirement of oxytocin and its mean dose <br/ ><br>Timepoint: 4 weeks <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.Active phase to delivery interval <br/ ><br>2.Mode of delivery <br/ ><br>3.Maternal side effects <br/ ><br>4.APGAR Score <br/ ><br>5.NICU Admissions <br/ ><br>Timepoint: 4 weeks